Analytics

Mar 01, 2016
BioPharm International
Collaborative efforts are underway between suppliers and drug manufacturers to address raw material variability.
Mar 01, 2016
BioPharm International
The necessity to detach cells from a culture substrate during cell harvesting remains one of the most challenging steps in a cell-culture process.
Mar 01, 2016
BioPharm International
The authors describe the ways in which manufacturers can mitigate the risks related to the integrity of recombinant transgenes expressed in CHO cells.
Feb 26, 2016
By BioPharm International Editors
The advanced capillary electrophoresis system, Maurice, from ProteinSimple is used for the quantitative analysis of identity, purity, and heterogeneity profiles of biopharmaceuticals.
Feb 09, 2016
Researchers describe a new method to compare the higher-order structure of a reference biologic with its proposed biosimilar product candidates.
Feb 01, 2016
BioPharm International
The recognition that microbial artifacts are capable of modulating the mammalian immune system is an emerging view of biologic drug contamination control testing.
Feb 01, 2016
BioPharm International
Understanding of the risks associated with FMEA is crucial in lot release testing.
Feb 01, 2016
BioPharm International
Time and sensitivity are essential for analytical technologies in all phases of biopharma development.
Jan 20, 2016
By BioPharm International Editors
The European Pharmacopoeia rewrites in its general chapter on Raman spectroscopy.
Jan 01, 2016
BioPharm International
This article defines the concept, justification, and method of removal of out-of-trend points in stability modelling and shelf-life prediction.
native1_300x100
lorem ipsum